Prognostic impact of pre‐referral tumor resection in unilateral Wilms tumor: A single‐institute experience from a lower middle‐income country

Author:

Khan Muhammad Saghir1ORCID,Maaz Ata Ur Rehman2ORCID,Qazi Abid Quddus3,Aslam Sophia4,Riaz Shazia5,Malik Ayesha Saeed6,Shaheen Najma7

Affiliation:

1. Department of Pediatrics King Faisal Specialist Hospital and Research Center Al Madinah Al Munawarrah Saudi Arabia

2. Division of Hematology/Oncology Child Health, Sidra Medicine Doha Qatar

3. Pediatric Surgeon Al Jalila Children's Specialty Hospital Dubai Dubai United Arab Emirates

4. Pediatric Oncology Royal Victoria Infirmary Newcastle upon Tyne UK

5. Department of Pediatric Hematology/Oncology The Children's Hospital and Institute of Child Health Lahore Lahore Pakistan

6. Department of Pediatrics King Edward Medical University Lahore Pakistan

7. Department of Pediatric Oncology Shaukat Khanum Cancer Hospital and Research Center Lahore Pakistan

Abstract

AbstractIntroductionThe objectives of this study were to evaluate the prognostic impact of pre‐referral surgical resection of Wilms tumor (WT) performed at non‐oncology centers, and to strategize an improved care plan for this very curable pediatric tumor.MethodsIn this study conducted in a large pediatric cancer center in Pakistan, we retrospectively reviewed the electronic medical records (EMR) of 149 patients with unilateral WT from September 2008 to August 2017. Based on treatment approach, patients were categorized into two groups: (i) pre‐referral tumor resection (PTR: n = 75), and (ii) post‐neoadjuvant chemo nephrectomy (PCN: n = 74).ResultsThe proportion of metastatic disease in PTR and PCN groups was 33.3% and 35.1%, respectively. In the PTR subset, median time to admission after PTR was 5 weeks (mean 11, SEM 2.8, range: 2–202) weeks, with 53.3% (n = 40) presenting more than 4 weeks after PTR. Twenty patients had no cross‐sectional imaging prior to PTR and underwent surgery after abdominal ultrasound only. On baseline imaging at our center, 58.7% (n = 44) of the PTR group had radiologically evaluable disease (four metastases only, 19 local residual tumor only, 21 both localized tumor and visible metastases). Disease staging was uncertain in 23 patients because of no or inadequate histology specimens and/or lymph node sampling in patients with no evaluable disease. Statistically significant differences were recorded for the two subsets regarding tumor volume, extent and nodularity, renal vein and renal sinus involvement, lymph node status, tumor rupture and histopathologic features, and tumor stage, with a 10‐year event‐free survival (EFS) for PCN and PTR of 74.3% and 50.7%, respectively (p < .001). In the PTR group, EFS for those presenting within 4 weeks and later was 91.4% versus 15.0%, respectively (p < .0001).ConclusionSuboptimal pre‐referral surgical intervention results in poor survival outcomes in unilateral WT. Our findings highlight the need for a comprehensive action plan for educating healthcare professionals engaged in WT diagnosis and referral process. PCN in a multidisciplinary team approach can reduce surgical morbidity and seems to be a better strategy to improve the survival rates in low‐resource settings.

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3